COLLEGIUM PHARMACEUTICAL, INC (COLL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 300M 600M 900M Q3 '21: 325.8M Q4 '21: 276.9M Q1 '22: 272.9M Q2 '22: 313.5M Q3 '22: 361.7M Q4 '22: 463.9M Q1 '23: 524.9M Q2 '23: 536.9M Q3 '23: 546.6M Q4 '23: 566.8M Q1 '24: 566.9M Q2 '24: 576.7M Q3 '24: 599.2M Q4 '24: 631.4M Q1 '25: 664.3M Q2 '25: 707M Q3 '25: 757.1M Q4 '25: 780.6M Q1 '26: 796.3M Q2 '26: 808.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 200M 400M 600M Q3 '21: 196.2M Q4 '21: 150.6M Q1 '22: 143.5M Q2 '22: 145.6M Q3 '22: 158.4M Q4 '22: 209.5M Q1 '23: 238.4M Q2 '23: 259.9M Q3 '23: 281.3M Q4 '23: 326.2M Q1 '24: 340.2M Q2 '24: 357.2M Q3 '24: 373.7M Q4 '24: 377.3M Q1 '25: 383.2M Q2 '25: 400.8M Q3 '25: 433.2M Q4 '25: 463.3M Q1 '26: 483.2M Q2 '26: 485.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-70M 0 70M 140M 210M Q3 '21: 66.7M Q4 '21: 17.6M Q1 '22: -13.6M Q2 '22: -18.9M Q3 '22: -12.6M Q4 '22: 33.3M Q1 '23: 68M Q2 '23: 92.5M Q3 '23: 117M Q4 '23: 167M Q1 '24: 191.8M Q2 '24: 203.6M Q3 '24: 193.5M Q4 '24: 169.9M Q1 '25: 142.1M Q2 '25: 129.7M Q3 '25: 157M Q4 '25: 179.6M Q1 '26: 188.8M Q2 '26: 157.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-80M -40M 0 40M 80M 120M Q3 '21: 103.5M Q4 '21: 71.5M Q1 '22: 42.8M Q2 '22: -35.2M Q3 '22: -42.8M Q4 '22: -25M Q1 '23: -29.4M Q2 '23: -11.2M Q3 '23: 9M Q4 '23: 48.2M Q1 '24: 93.3M Q2 '24: 99.9M Q3 '24: 88.6M Q4 '24: 69.2M Q1 '25: 43.9M Q2 '25: 36.3M Q3 '25: 58.4M Q4 '25: 62.9M Q1 '26: 74.9M Q2 '26: 47.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 150M 300M 450M Q3 '21: 129.5M Q4 '21: 126.3M Q1 '22: 129.4M Q2 '22: 167.9M Q3 '22: 203.3M Q4 '22: 254.4M Q1 '23: 286.6M Q2 '23: 277.1M Q3 '23: 265.3M Q4 '23: 240.6M Q1 '24: 226.7M Q2 '24: 219.4M Q3 '24: 225.6M Q4 '24: 254.1M Q1 '25: 281.1M Q2 '25: 306.2M Q3 '25: 323.9M Q4 '25: 317.3M Q1 '26: 313.2M Q2 '26: 323.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

0 150M 300M 450M Q3 '21: 89.9M Q4 '21: 103.6M Q1 '22: 57.7M Q2 '22: 68.6M Q3 '22: 94.1M Q4 '22: 124.2M Q1 '23: 177.2M Q2 '23: 236.5M Q3 '23: 267.7M Q4 '23: 274.7M Q1 '24: 309M Q2 '24: 276.7M Q3 '24: 193.7M Q4 '24: 205M Q1 '25: 198.4M Q2 '25: 203.5M Q3 '25: 290.9M Q4 '25: 329.3M Q1 '26: 331M Q2 '26: 329.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

0 150M 300M 450M Q3 '21: 87M Q4 '21: 101.6M Q1 '22: 56M Q2 '22: 67.2M Q3 '22: 92.9M Q4 '22: 122.6M Q1 '23: 175.5M Q2 '23: 235.2M Q3 '23: 266.5M Q4 '23: 274.3M Q1 '24: 308.2M Q2 '24: 275.6M Q3 '24: 192.4M Q4 '24: 203.3M Q1 '25: 196.6M Q2 '25: 201.8M Q3 '25: 289.3M Q4 '25: 327.6M Q1 '26: 329.8M Q2 '26: 328.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q3 '21: 36.3M Q4 '21: 34.1M Q1 '22: 33.7M Q2 '22: 34M Q3 '22: 34.6M Q4 '22: 33.6M Q1 '23: 34.3M Q2 '23: 42.8M Q3 '23: 42.1M Q4 '23: 41.3M Q1 '24: 41.4M Q2 '24: 40.4M Q3 '24: 40.2M Q4 '24: 40.1M Q1 '25: 32.8M Q2 '25: 39.1M Q3 '25: 39.4M Q4 '25: 40.1M Q1 '26: 40.1M Q2 '26: 32.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-1.80 -0.90 0.00 0.90 1.80 2.70 Q3 '21: 2.62 Q4 '21: 1.69 Q1 '22: 0.89 Q2 '22: -1.05 Q3 '22: -1.26 Q4 '22: -0.74 Q1 '23: -0.86 Q2 '23: -0.37 Q3 '23: 0.15 Q4 '23: 1.18 Q1 '24: 2.40 Q2 '24: 2.58 Q3 '24: 2.32 Q4 '24: 1.86 Q1 '25: 1.22 Q2 '25: 1.04 Q3 '25: 1.61 Q4 '25: 1.71 Q1 '26: 2.04 Q2 '26: 1.24 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.